Skip to main content
S 4691 118th Congress Senate Taxation

No Tax Breaks for Drug Ads Act

Introduced: July 11, 2024 Introduced by: Shaheen, Jeanne Democratic · New Hampshire See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 11, 2024
Read twice and referred to the Committee on Finance.
Jul 11, 2024
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

No Tax Breaks for Drug Ads Act

This bill disallows any tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs.

What's happening now July 11, 2024

Read twice and referred to the Committee on Finance.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 4691: No Tax Breaks for Drug Ads Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-4691/
MLA
"S. 4691: No Tax Breaks for Drug Ads Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-4691/.
Bluebook (legal)
S. 4691, 118th Cong. (2026), https://openamerica.io/bill/118-S-4691/.
Markdown link
[S. 4691: No Tax Breaks for Drug Ads Act](https://openamerica.io/bill/118-S-4691/)
Report a problem